IRIS
PREZIOSA, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.475
EU - Europa 6.075
AS - Asia 5.940
SA - Sud America 1.182
Continente sconosciuto - Info sul continente non disponibili 633
AF - Africa 145
OC - Oceania 17
Totale 20.467
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.024
RU - Federazione Russa 3.253
SG - Singapore 2.173
CN - Cina 1.804
IT - Italia 1.261
BR - Brasile 925
HK - Hong Kong 765
VN - Vietnam 488
SE - Svezia 358
FR - Francia 307
DE - Germania 285
CA - Canada 200
GB - Regno Unito 173
BD - Bangladesh 141
IN - India 131
FI - Finlandia 102
AR - Argentina 99
MX - Messico 83
IR - Iran 59
NL - Olanda 59
PL - Polonia 57
TR - Turchia 56
EC - Ecuador 51
ZA - Sudafrica 49
JP - Giappone 47
ES - Italia 46
IQ - Iraq 42
AT - Austria 41
ID - Indonesia 37
SA - Arabia Saudita 34
CR - Costa Rica 33
CO - Colombia 32
JM - Giamaica 31
IE - Irlanda 25
VE - Venezuela 25
EG - Egitto 23
MA - Marocco 21
LT - Lituania 18
PK - Pakistan 17
AE - Emirati Arabi Uniti 16
BE - Belgio 16
KE - Kenya 16
MY - Malesia 16
PT - Portogallo 16
IL - Israele 15
PY - Paraguay 15
CL - Cile 14
SV - El Salvador 14
UZ - Uzbekistan 14
AU - Australia 13
HN - Honduras 13
TT - Trinidad e Tobago 13
PR - Porto Rico 12
TN - Tunisia 12
GT - Guatemala 11
PE - Perù 11
UA - Ucraina 11
CH - Svizzera 10
NP - Nepal 10
GP - Guadalupe 7
JO - Giordania 7
KR - Corea 7
LB - Libano 7
MD - Moldavia 7
NI - Nicaragua 7
RO - Romania 7
UY - Uruguay 7
AZ - Azerbaigian 6
BB - Barbados 6
CY - Cipro 6
NO - Norvegia 6
TW - Taiwan 6
AO - Angola 5
KZ - Kazakistan 5
NG - Nigeria 5
PA - Panama 5
TH - Thailandia 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
BH - Bahrain 3
CI - Costa d'Avorio 3
GR - Grecia 3
KH - Cambogia 3
OM - Oman 3
PH - Filippine 3
PS - Palestinian Territory 3
AL - Albania 2
BO - Bolivia 2
BZ - Belize 2
CU - Cuba 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GA - Gabon 2
GD - Grenada 2
HT - Haiti 2
QA - Qatar 2
AG - Antigua e Barbuda 1
Totale 19.814
Salva come PNG Salva come JPEG
Città #
Singapore 1.036
Dallas 985
Ashburn 867
Hong Kong 741
Moscow 723
San Jose 718
Milan 353
Council Bluffs 350
Beijing 301
Hefei 252
Shanghai 225
Lauterbourg 220
Ho Chi Minh City 181
New York 180
Phoenix 148
Los Angeles 141
Hanoi 118
Santa Clara 116
Rome 112
Princeton 99
Lawrence 97
São Paulo 93
Munich 88
Boardman 70
Helsinki 58
Orem 56
Nuremberg 48
Miano 45
Montreal 44
Mexico City 43
Chennai 41
Atlanta 39
Denver 38
Frankfurt am Main 38
Guangzhou 38
Warsaw 38
Carrboro 37
Rio de Janeiro 37
Chicago 36
Tokyo 34
Boston 32
Brooklyn 32
Naples 31
Houston 29
Poplar 28
London 27
Johannesburg 26
San José 25
Ankara 24
Cesano Boscone 24
Da Nang 24
Dublin 24
Stockholm 24
Laval 23
Philadelphia 23
The Dalles 23
Turku 23
Buffalo 22
Haiphong 22
Shenzhen 22
Amsterdam 21
Belo Horizonte 21
Manchester 21
Tianjin 21
Tehran 20
Turin 20
Baghdad 19
Charlotte 19
Las Vegas 19
Miami 19
Brasília 18
Curitiba 18
Genoa 18
Lappeenranta 18
Mumbai 18
Seattle 18
Washington 18
Guayaquil 17
Istanbul 17
Toronto 17
Vienna 17
Bologna 16
Kingston 15
New Delhi 15
Palermo 15
Pittsburgh 15
Quito 15
Radebeul 15
San Francisco 15
Calgary 14
Hangzhou 14
Queens 14
Cairo 13
Columbus 13
San Salvador 13
Biên Hòa 12
Brescia 12
Campinas 12
Dhaka 12
North Bergen 12
Totale 10.048
Salva come PNG Salva come JPEG
Nome #
Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4) 381
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 199
A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging 179
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 169
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis 168
Impact of Multiple Sclerosis on Cognitive Aging: A Multicenter Study 166
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability 166
Gray matter damage predicts the accumulation of disability 13 years later in MS. 155
Dynamic functional connectivity of thalamic sub-regions shows divegent patterns in multiple sclerosis phenotypes 153
Tolebrutinib for non-relapsing secondary progressive multiple sclerosis: a critical therapeutic gap 149
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 142
Voxel-wise multimodal MRI reveals specific patterns of brain damage in the main multiple sclerosis phenotypes 134
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 134
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 133
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 133
Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis 133
Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis 131
Cognitive Reserve Modulates the Impact of Structural Damage of the Frontal Lobe on Executive Functioning in Multiple Sclerosis (P1-1.Virtual) 131
Monoaminergic network abnormalities: a marker for multiple sclerosis-related fatigue and depression 128
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis 126
Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis 126
Diagnosis of Progressive Multiple Sclerosis from the Imaging Perspective: A Review 126
In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI 125
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics 124
Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study 124
Chronic Active Lesions and Larger Choroid Plexus Explain Cognition and Fatigue in Multiple Sclerosis 123
Resting State Functional Connectivity Correlates of Executive Function in Patients with Multiple Sclerosis 117
Functional and structural MRI correlates of executive functions in multiple sclerosis 117
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives 111
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 110
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis 109
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 109
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines 108
Subventricular Zone Microstructure in Pediatric-Onset Multiple Sclerosis 108
Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer's disease 107
Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series 104
A semiautomatic method for multiple sclerosis lesion segmentation on dual-echo MR imaging: application in a multicenter context 104
Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis 103
Advances in neuroimaging of multiple sclerosis 103
Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives 103
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 102
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis 102
Aerobic capacity moderates the association between cervical cord atrophy and clinical disability in mildly disabled multiple sclerosis patients 102
Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex 101
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study 101
Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis 101
Cervical spinal cord gray matter damage predicts disability worsening in multiple sclerosis: a longitudinal study 100
Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients 100
Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis 100
Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression 99
Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study 98
Dynamics of choroid plexus volume is associated with the presence and development of fatigue in multiple sclerosis 97
Action observation training promotes motor improvement and modulates functional network dynamic connectivity in multiple sclerosis 97
Brain and cervical spinal cord MRI correlates of sensorimotor impairment in patients with multiple sclerosis 96
Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family 96
Action observation training modifies brain gray matter structure in healthy adult individuals 96
Radiologically isolated syndromes: to treat or not to treat? 95
Association between pathological and MRI findings in multiple sclerosis 95
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 95
Spinal Cord Abnormalities in Early Pediatric Multiple Sclerosis 94
Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19? 94
Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability 93
A demyelinating disorder characterized by repeated episodes of optic neuritis and brainstem dysfuntions in a girl with anti-MOG positivity 92
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 91
Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis 91
Correction to: Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders (Journal of Neurology, (2024), 271, 7, (3879-3896), 10.1007/s00415-024-12426-w) 91
Divergent time-varying connectivity of thalamic sub-regions characterizes clinical phenotypes and cognitive status in multiple sclerosis 90
Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein–immunoglobulin G-associated Disease 89
Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex 89
Correspondence between gray matter atrophy and neurotransmitter maps is relevant in multiple sclerosis 88
Assessment of central vein sign and paramagnetic rim lesions in pediatric multiple sclerosis 88
Clinical relevance of spatial correspondence between regional gene expression and grey matter atrophy in multiple sclerosis 88
Paramagnetic rim lesion burden and choroid plexus enlargement contribute to cognitive impairment and fatigue in multiple sclerosis 88
Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR Study 88
Human functional MRI 87
Choroid plexus and perivascular spaces enlargement in neuropsychiatric systemic lupus erythematosus 85
Artificial Intelligence Applied on Conventional Magnetic Resonance Images Improves the Correct Diagnosis of CNS Diseases Mimicking Multiple Sclerosis 85
Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders 84
Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis 84
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication 84
The ageing central nervous system in multiple sclerosis: the imaging perspective 83
Artificial intelligence applied on conventional magnetic resonance images improves the correct diagnosis of CNS diseases mimicking multiple sclerosis 83
What role should spinal cord MRI take in the future of multiple sclerosis surveillance? 83
The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis 82
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis 82
Can post-mortem MRI be used as a proxy for in vivo? A case study 81
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 81
Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study 81
Application of DIR and DT MRI to quantify focal and diffuse cortical damage in MS. 80
Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis 80
MRI of Transcallosal White Matter Helps to Predict Motor Impairment in Multiple Sclerosis 80
Clinical integration of brain and cord MRI features improves differential diagnosis of multiple sclerosis 79
Randomized controlled trials for multiple sclerosis: integrating pathology-driven outcomes to capture therapeutic efficacy 78
Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment 78
Different CSF-in gradients of damage occur in the thalamus, caudate nucleus and cortex in multiple sclerosis: a 3T magnetization transfer ratio and R2*study 77
Use of brain MRI and gene expression atlases to reconstruct the pathophysiology of autoimmune neurological disorders: The proof-of-concept of NMOSD 77
Information from ecological momentary assessments leads to over-medicalization: No 77
Clinically isolated syndromes suggestive of multiple sclerosis: dynamic patterns of gray and white matter changes - a 2 year MR imaging study 77
Current state-of-art of the application of serum neurofilaments in multiple sclerosis diagnosis and monitoring 76
Age Matters in Multiple Sclerosis: Novel Insights Into Disease Progression From Clinical Onset 75
Totale 10.797
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.739
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022120 0 0 0 40 2 10 11 19 15 7 9 7
2022/2023737 225 116 57 8 21 79 25 42 66 31 20 47
2023/2024725 32 46 52 111 65 81 59 68 9 53 49 100
2024/20253.468 250 97 102 85 124 183 256 357 688 568 287 471
2025/202612.020 914 948 1.052 1.599 834 313 989 849 3.008 801 401 312
2026/20273.278 436 796 745 1.301 0 0 0 0 0 0 0 0
Totale 20.467